OnCo
peoplePerson

Jin Li

Principal investigator of FRESCO, the Chinese trial that first proved fruquintinib works in refractory colorectal cancer.

Jin Li led FRESCO (fruquintinib) and other Chinese GI oncology trials including apatinib in gastric cancer, contributing drugs now used internationally.

Role
Professor of Medical Oncology, Fudan University Shanghai Cancer Center and Shanghai East Hospital; gastrointestinal oncology
Specialisms
Colorectal cancerGastric cancerTargeted therapyClinical trials

Papers

1top
TitleJournalYear
Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trialJAMA2018

Connected

6top

Pages like this

not linked directly; found by shared links

cancers

2
Colorectal cancerGastric & gastro-oesophageal junction cancer

drugs

1
ApprovedSmall-molecule kinase inhibitor (VEGFR1-3)
Fruquintinib · Fruzaqla

institutions

2
Chinese Society of Clinical OncologyFudan University Shanghai Cancer Center

trials

1
FRESCO-2